Nuclear cloning of embryonal carcinoma cells
Open accessThe DOI matches its OpenAlex record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Embryonal carcinoma (EC) cells have served as a model to study the relationship between cancer and cellular differentiation given their potential to produce tumors and, to varying degrees, participate in embryonic development. Here, nuclear transplantation was used to assess the extent to which the tumorigenic and developmental potential of EC cells is governed by epigenetic as opposed to genetic alterations. Nuclei from three independent mouse EC cell lines (F9, P19, and METT-1) with differing developmental and tumorigenic potentials all were able to direct early embryo development, producing morphologically normal blastocysts that gave rise to nuclear transfer (NT)-derived embryonic stem (ES) cell lines at a high efficiency. However, when tested for tumor or chimera formation, the resulting NT ES cells displayed an identical potential as their respective donor EC cells, in stark contrast to previously reported NT ES cells derived from transfer of untransformed cells. Consistent with this finding, comparative genomic hybridization identified previously undescribed genetic lesions in the EC cell lines. Therefore, nonreprogrammable genetic modifications within EC nuclei define the developmental and tumorigenic potential of resulting NT ES cells. Our findings support the notion that cancer results from the deregulation of stem cells and further suggest that the genetics of ECs will reveal genes involved in stem cell self-renewal and pluripotency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Chromatin modification and epigenetic reprogramming in mammalian development
Li, E. (2002) · Nature Reviews Genetics · doi:10.1038/nrg887 · Cited by 1,900
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
Artandi, S. E., Chang, S., Lee, S.-L., Alson, S., Gottlieb, G. J., Chin, L., & DePinho, R. A. (2000) · Nature · doi:10.1038/35020592 · Cited by 1,085
Self-citation
Cited by
DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal
Wang, Y., Medvid, R., Melton, C., Jaenisch, R., & Blelloch, R. (2007) · Nature Genetics · doi:10.1038/ng1969 · Cited by 1,025
Self-citationTesticular germ-cell tumours in a broader perspective
Oosterhuis, J. W., & Looijenga, L. H. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1568 · Cited by 916
Regulatory networks in embryo-derived pluripotent stem cells
Boiani, M., & Schöler, H. R. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1744 · Cited by 664
Epigenetic reprogramming and induced pluripotency
Hochedlinger, K., & Plath, K. (2009) · Development · doi:10.1242/dev.020867 · Cited by 553
Nuclear reprogramming and pluripotency
Hochedlinger, K., & Jaenisch, R. (2006) · Nature · doi:10.1038/nature04955 · Cited by 463
The Tumorigenicity of Human Embryonic Stem Cells
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)00005-5 · Cited by 451
Zscan4 regulates telomere elongation and genomic stability in ES cells
Zalzman, M., Falco, G., Sharova, L. V., Nishiyama, A., Thomas, M., Lee, S.-L., Stagg, C. A., Hoang, H. G., Yang, H.-T., Indig, F. E., et al. (2010) · Nature · doi:10.1038/nature08882 · Cited by 441
The promise of human induced pluripotent stem cells for research and therapy
Nishikawa, S.-I., Goldstein, R. A., & Nierras, C. R. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2466 · Cited by 421
From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research
Solter, D. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1827 · Cited by 326
Taranger, C. K., Noer, A., Sørensen, A. L., Håkelien, A.-M., Boquest, A. C., & Collas, P. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-06-0572 · Cited by 286
Blelloch, R., Wang, Z., Meissner, A., Pollard, S., Smith, A., & Jaenisch, R. (2006) · STEM CELLS · doi:10.1634/stemcells.2006-0050 · Cited by 277
Self-citationDiet, Nutrition, and Cancer Epigenetics
Sapienza, C., & Issa, J.-P. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-121415-112634 · Cited by 194
Lin, Y., Yang, Y., Li, W., Chen, Q., Li, J., Pan, X., Zhou, L., Liu, C., Chen, C., He, J., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.030 · Cited by 190
“Finally, F9 cells were more tumorigenic than P19 cells in xenografting experiments (Figure 6F), which is consistent with previous findings obtained from teratoma formation assays, nuclear cloning assays (Blelloch et al., 2004), andmouse embryo transplantation (Astigiano et al., 2005).”
ResultPatient-derived induced pluripotent stem cells in cancer research and precision oncology
Papapetrou, E. P. (2016) · Nature Medicine · doi:10.1038/nm.4238 · Cited by 160
Chromatin Decondensation and Nuclear Reprogramming by Nucleoplasmin
Tamada, H., Thuan, N. V., Reed, P., Nelson, D., Katoku-Kikyo, N., Wudel, J., Wakayama, T., & Kikyo, N. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1259-1271.2006 · Cited by 120
Metadata
- Authors
- Blelloch, R. H.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-08-11
- Volume
- 101
- Issue
- 39
- Pages
- 13985-90
- ISSN
- 0027-8424 (ISSN-L)
- OpenAlex
- W2144517755
- Cited by
- 167
- References
- 4
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.